NDC product
E.E.S 400
NDC 24338-100 · Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
Key facts
| Product NDC | 24338-100 |
|---|---|
| Proprietary name | E.E.S |
| Nonproprietary name | Erythromycin Ethylsuccinate |
| Substances | ERYTHROMYCIN ETHYLSUCCINATE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA061905 |
| Pharmacologic classes | Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS] |
| Marketing start | May 3, 2011 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: